SEC Filing Details

Document Details

Form
Filing Date
Mar 25, 2020
Document Date
Mar 23, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
Svennilson Peter

Stock Quote

Contact Information

Investor Relations:
ir@ngmbio.com

Media Relations:
media@ngmbio.com

Top